I have to agree with you somewhat, the webinar was fantasy.
More about having conversations with potential partners , consumers and so on.
The only concrete outcomes we have to look forward to are(hopefully);
1. TGA self use RAT approval 2. Febridx FDA approval, 3. additional corporate clients for Professional RAT ( subject to the product passing the current review process).
If the above are achieved , our share price should edge up.
AT1 Price at posting:
20.0¢ Sentiment: Hold Disclosure: Held
